Alan Boyd

4.2k total citations
72 papers, 2.6k citations indexed

About

Alan Boyd is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan Boyd has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 24 papers in Genetics and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan Boyd's work include Bacterial Genetics and Biotechnology (13 papers), Cystic Fibrosis Research Advances (12 papers) and Neonatal Respiratory Health Research (12 papers). Alan Boyd is often cited by papers focused on Bacterial Genetics and Biotechnology (13 papers), Cystic Fibrosis Research Advances (12 papers) and Neonatal Respiratory Health Research (12 papers). Alan Boyd collaborates with scholars based in United Kingdom, United States and Germany. Alan Boyd's co-authors include Melvin I. Simon, Michael J. R. Stark, David J. Porteous, I. Barry Holland, Norihiro Mutoh, Leonora F. Ciufo, Nia J. Bryant, J. Alastair Innes, David J. Sherratt and Richard H. Ashley and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Alan Boyd

69 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Boyd United Kingdom 30 1.8k 806 405 344 213 72 2.6k
David Shin United States 26 2.6k 1.5× 547 0.7× 151 0.4× 155 0.5× 294 1.4× 49 4.3k
C. F. Higgins United Kingdom 25 1.5k 0.8× 785 1.0× 577 1.4× 89 0.3× 93 0.4× 35 2.6k
David M. Bedwell United States 41 4.0k 2.3× 774 1.0× 1.1k 2.8× 442 1.3× 291 1.4× 81 5.4k
Stuart W. Peltz United States 53 7.6k 4.3× 778 1.0× 229 0.6× 357 1.0× 424 2.0× 123 8.9k
Jaime Renart Spain 26 1.8k 1.0× 268 0.3× 111 0.3× 206 0.6× 201 0.9× 60 2.9k
F. Lottspeich Germany 28 2.4k 1.4× 281 0.3× 110 0.3× 456 1.3× 451 2.1× 52 3.4k
Frederic A. Troy United States 40 3.4k 1.9× 684 0.8× 90 0.2× 654 1.9× 159 0.7× 94 4.6k
L. Thim Denmark 37 2.9k 1.6× 404 0.5× 232 0.6× 291 0.8× 242 1.1× 97 5.4k
Paul A. Negulescu United States 27 2.1k 1.2× 273 0.3× 1.2k 3.0× 318 0.9× 153 0.7× 41 4.2k
Roger Dawson Switzerland 17 2.4k 1.4× 243 0.3× 208 0.5× 118 0.3× 110 0.5× 27 3.7k

Countries citing papers authored by Alan Boyd

Since Specialization
Citations

This map shows the geographic impact of Alan Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Boyd more than expected).

Fields of papers citing papers by Alan Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Boyd. The network helps show where Alan Boyd may publish in the future.

Co-authorship network of co-authors of Alan Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Boyd. A scholar is included among the top collaborators of Alan Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Boyd. Alan Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Griesenbach, Uta, Gerry McLachlan, Cédric Cheminay, et al.. (2023). WS17.06 F/HN pseudotyped lentiviral vector-mediated transduction of non-human primates. Journal of Cystic Fibrosis. 22. S33–S33. 1 indexed citations
3.
McLachlan, Gerry, Eric W.F.W. Alton, Alan Boyd, et al.. (2022). Progress in Respiratory Gene Therapy. Human Gene Therapy. 33(17-18). 893–912. 17 indexed citations
4.
Meador, Kimford J., Alexandre E. Medina, Sílvia M. Illamola, et al.. (2021). Vinpocetine, cognition, and epilepsy. Epilepsy & Behavior. 119. 107988–107988. 18 indexed citations
5.
Alton, Eric W.F.W., Alan Boyd, Jane C. Davies, et al.. (2016). Genetic medicines for CF: Hype versus reality. Pediatric Pulmonology. 51(S44). S5–S17. 36 indexed citations
6.
Alton, Eric W.F.W., Alan Boyd, David J. Porteous, et al.. (2015). A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial. American Journal of Respiratory and Critical Care Medicine. 192(11). 1389–1392. 40 indexed citations
7.
Alton, Eric W.F.W., Alan Boyd, Jane C. Davies, et al.. (2014). LARGE-SCALE PRODUCTION OF LENTIVIRAL VECTORS FOR CF LUNG GENE THERAPY. Pediatric Pulmonology. 49. 293–293. 1 indexed citations
8.
Griesenbach, Uta, Makoto Inoue, Cuixiang Meng, et al.. (2012). Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy. American Journal of Respiratory and Critical Care Medicine. 186(9). 846–856. 79 indexed citations
9.
Sousa, Marisa, et al.. (2010). Folding and Rescue of a Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Mutant Identified Using Human-Murine Chimeric Proteins. Journal of Biological Chemistry. 285(35). 27033–27044. 6 indexed citations
10.
Lacombe, Karine, Alan Boyd, Jean‐Michel Molina, et al.. (2008). 694 MDRD CREATININE CLEARANCE IS NOT ALTERED IN HIV-HBV CO-INFECTED PATIENTS WITH A NORMAL RENAL FUNCTION AND TREATED WITH TENOFOVIR (TDF). Journal of Hepatology. 48. S259–S259. 2 indexed citations
11.
MacGregor, Gordon, Robert D. Gray, M. Imrie, et al.. (2008). Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid. Journal of Cystic Fibrosis. 7(5). 352–358. 36 indexed citations
12.
Boyd, Alan, Leonora F. Ciufo, Jeff W. Barclay, et al.. (2008). A Random Mutagenesis Approach to Isolate Dominant-Negative Yeastsec1Mutants Reveals a Functional Role for Domain 3a in Yeast and Mammalian Sec1/Munc18 Proteins. Genetics. 180(1). 165–178. 29 indexed citations
13.
Carpp, Lindsay N., et al.. (2006). The Sec1p/Munc18 protein Vps45p binds its cognate SNARE proteins via two distinct modes. The Journal of Cell Biology. 173(6). 927–936. 89 indexed citations
14.
Gray, Robert D., M. Imrie, Alan Boyd, et al.. (2006). Development of sputum calprotectin as a biomarker of cystic fibrosis lung disease activity: Evidence from cross sectional and longitudinal studies. Thorax. 61. 1 indexed citations
15.
Gray, Robert D., M. Imrie, J. Alastair Innes, et al.. (2006). Sputum metal ions are biomarkers for suppurative and inflammatory lung disease. Thorax. 61.
16.
Boyd, Alan. (2001). Gene therapy for cystic fibrosis. Expert Opinion on Therapeutic Patents. 11(1). 1–15. 16 indexed citations
17.
Ciufo, Leonora F. & Alan Boyd. (2000). Identification of a Lumenal Sequence Specifying the Assembly of Emp24p into p24 Complexes in the Yeast Secretory Pathway. Journal of Biological Chemistry. 275(12). 8382–8388. 45 indexed citations
18.
Mullins, L. J., et al.. (1997). Efficient Cre-lox linearisation of BACs: applications to physical mapping and generation of transgenic animals. Nucleic Acids Research. 25(12). 2539–2540. 20 indexed citations
19.
Bryant, Nia J. & Alan Boyd. (1993). Immunoisolation of Kex2p-containing organelles from yeast demonstrates colocalisation of three processing proteinases to a single Golgi compartment. Journal of Cell Science. 106(3). 815–822. 35 indexed citations
20.
Boyd, Alan & Melvin I. Simon. (1982). Bacterial Chemotaxis. Annual Review of Physiology. 44(1). 501–517. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Shin Breakdown of academic impact, for papers by C. F. Higgins Breakdown of academic impact, for papers by David M. Bedwell Breakdown of academic impact, for papers by Stuart W. Peltz Breakdown of academic impact, for papers by Jaime Renart Breakdown of academic impact, for papers by F. Lottspeich Breakdown of academic impact, for papers by Frederic A. Troy Breakdown of academic impact, for papers by L. Thim Breakdown of academic impact, for papers by Paul A. Negulescu Breakdown of academic impact, for papers by Roger Dawson
Rankless by CCL
2026